CYTRX CORP
S-3/A, EX-23.2, 2000-06-23
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: CYTRX CORP, S-3/A, 2000-06-23
Next: MFS MUNICIPAL INCOME TRUST, N-30D, 2000-06-23



<PAGE>

                                                                    Exhibit 23.2

                        CONSENT OF INDEPENDENT AUDITORS


We consent to the reference to our firm under the caption "Experts" in Amendment
No. 2 to the Registration Statement on Form S-3 (No. 333-33792) and related
Prospectus of CytRx Corporation for the registration of 2,606,092 shares of its
common stock and to the incorporation by reference therein of our report dated
March 15, 2000, except for Note 13, paragraphs 10 and 11, as to which the date
is June 15, 2000 with respect to the restated consolidated financial statements
and schedule of CytRx Corporation included in its Current Report on Form 8-K
dated June 18, 2000, filed with the Securities and Exchange Commission.


                                         /s/ ERNST & YOUNG LLP


Atlanta, Georgia
June 21, 2000


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission